UK Clinical Pharmacy Association

Pridinol

Issues for surgery

Loss of control of spasticity if omitted.

Advice in the perioperative period

Elective and emergency surgery 

Continue.

Post-operative advice

Restart post-operatively when enteral intake resumes and next dose due, manufacturer recommends tablets should be taken with sufficient fluid (e.g. a glass of water) and swallowed whole.

Review if patient develops reduced gastrointestinal obstruction post-operatively. 

Interactions with common anaesthetic agents

Antimuscarinic action

Antimuscarinic action of pridinol may be additive with agents that also have antimuscarinic effects such as atropine and glycopyronnium. 

Interactions with other common medicines used in the perioperative period

Antimuscarinic action

Antiemetics

Antimuscarinic action of pridinol may be additive with antiemetics that also have antimuscarinic effects such as cyclizine, haloperidol, levomepromazine or prochlorperazine. 

Nefopam

Antimuscarinic action of pridinol may be additive with nefopam which also has antimuscarinic effects.

Further information

None relevant

References

Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. http://www.medicinescomplete.com [Accessed on 28th May 2024]

Summary of Product Characteristics – Myopridin® (pridinol) 3mg tablets. Mibe Pharm UK Limited. Accessed via https://products.mhra.gov.uk 28/05/2024 [date of revision of the text March 2023]